|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes |
IUPAC Name ![]() |
| 5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 3073 | fenoterol |
Synonyms ![]() |
| Berotec® |
| TH-1165A |
Database Links ![]() |
|
| BindingDB Ligand | 50131281 |
| CAS Registry No. | 1944-10-1 (source: NCI) |
| ChEBI | CHEBI:149226 |
| ChEMBL Ligand | CHEMBL32800 |
| DrugBank Ligand | DB01288 |
| PharmGKB Drug | PA10079 |
| PubChem CID | 3343 |
| Search Google for chemical match using the InChIKey | LSLYOANBFKQKPT-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | LSLYOANBFKQKPT |
| Search PubMed clinical trials | fenoterol |
| Search PubMed titles | fenoterol |
| Search PubMed titles/abstracts | fenoterol |
| Wikipedia | Fenoterol |
| Comments |
| Fenoterol is a short-acting β2-adrenoceptor agonist (sympathomimetic) drug. The clinically used drug is a racemic mixture of enantiomers. We show the structure without specified stereochemistry to represent the mixture. The (S,R) and (R,S) enantiomers are much less active tha the (S,S) and (R,R) enantiomers. |